Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

KKailera Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
K

Kailera Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 7, 2026Nicholson NurChief Technology Officer220,000Stock Option (right to buy)—Grant / award
Jul 6, 2026Tregoning KathleenSee Remarks175,000Stock Option (right to buy)—Grant / award
Jun 9, 2026Renaud Ronald C JRCEO & President38,094Common Stock—Option exercise
Apr 20, 2026Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner11,511,852Common Stock—Conversion
Apr 20, 2026RTW INVESTMENTS, LP10% Owner500,000Common Stock—Buy
Apr 20, 2026RTW INVESTMENTS, LP10% Owner10,276,820Common Stock—Conversion
Apr 20, 2026Kaplan Andrew T.Director, 10% Owner8,398,438Common Stock—Buy
Apr 20, 2026Kaplan Andrew T.Director, 10% Owner17,857,143Common Stock—Conversion
Apr 20, 2026Bain Capital Life Sciences Investors, LLC10% Owner1,562,500Common Stock—Buy
Apr 20, 2026Bain Capital Life Sciences Investors, LLC10% Owner21,020,768Common Stock—Conversion
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions